These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18555881)

  • 1. [Manic-depressive psychosis as prevalent manifestation of multiple sclerosis].
    El Moutawakil B; Sibai M; Bourezgui M; Boulaajaj FZ; Rafai MA; Gam I; Slassi I
    Rev Neurol (Paris); 2008 May; 164(5):472-6. PubMed ID: 18555881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.
    Hotier S; Maltete D; Bourre B; Jegouzo X; Bourgeois V; Guillin O
    Gen Hosp Psychiatry; 2015; 37(6):621.e1-2. PubMed ID: 26321022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inaugural psychotic events in multiple sclerosis?].
    Blanc F; Berna F; Fleury M; Lita L; Ruppert E; Ferriby D; Vermersch P; Vidailhet P; de Seze J
    Rev Neurol (Paris); 2010 Jan; 166(1):39-48. PubMed ID: 19735928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychotic crisis symptomatic of an outbreak of multiple sclerosis].
    Zarranz JJ; Antigüedad AR; Bárcena J
    Neurologia; 1995 May; 10(5):205-8. PubMed ID: 7619539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and parkinsonism: a case report.
    Ozturk V; Idiman E; Sengun IS; Yuksel Z
    Funct Neurol; 2002; 17(3):145-7. PubMed ID: 12549720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Foreign language syndrome as a first sign of multiple sclerosis].
    Villaverde-González R; Fernández-Villalba E; Moreno-Escribano A; Alías-Linares E; García-Santos JM
    Rev Neurol; 2003 Jun 1-15; 36(11):1035-9. PubMed ID: 12808499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement disorders in multiple sclerosis: Causal or coincidental association?
    Nociti V; Bentivoglio AR; Frisullo G; Fasano A; Soleti F; Iorio R; Loria G; Patanella AK; Marti A; Tartaglione T; Tonali PA; Batocchi AP
    Mult Scler; 2008 Nov; 14(9):1284-7. PubMed ID: 18768580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonism and multiple sclerosis--is there association?
    Barun B; Brinar VV; Zadro I; Lusić I; Radović D; Habek M
    Clin Neurol Neurosurg; 2008 Nov; 110(9):958-61. PubMed ID: 18482794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurosarcoidosis as a cause of manic psychosis].
    De Mulder D; Vandenberghe J
    Tijdschr Psychiatr; 2008; 50(11):741-5. PubMed ID: 18991235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Lassmann H
    Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riedel's thyroiditis in a patient with multiple sclerosis.
    Kotilainen P; Airas L; Kojo T; Kurki T; Kataja K; Minn H; Nuutila P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):67-8. PubMed ID: 15726023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manic syndrome associated with multiple sclerosis: secondary mania?
    Mapelli G; Ramelli E
    Acta Psychiatr Belg; 1981; 81(4):337-49. PubMed ID: 7331840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Marburg variant multiple sclerosis with mitoxantrone.
    Jeffery DR; Lefkowitz DS; Crittenden JP
    J Neuroimaging; 2004 Jan; 14(1):58-62. PubMed ID: 14748210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing and treating common psychiatric disorders in multiple sclerosis.
    Wilken JA; Sullivan C
    Neurologist; 2007 Nov; 13(6):343-54. PubMed ID: 18090712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxysmal dyskinesias as the initial manifestation of multiple sclerosis].
    Masjuán J; Buisán J; Gimeno A; Alvarez-Cermeño JC
    Neurologia; 1998 Jan; 13(1):45-8. PubMed ID: 9580272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal dystonia and pathological laughter as a first manifestation of multiple sclerosis.
    Aguirregomozcorta M; Ramió-Torrentà L; Gich J; Quiles A; Genís D
    Mult Scler; 2008 Mar; 14(2):262-5. PubMed ID: 17942514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.